Connor Clark & Lunn Investment Management Ltd. lifted its position in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 438.7% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 145,257 shares of the company's stock after purchasing an additional 118,292 shares during the quarter. Connor Clark & Lunn Investment Management Ltd. owned about 0.09% of Option Care Health worth $4,547,000 at the end of the most recent quarter.
Several other institutional investors have also recently made changes to their positions in OPCH. Massachusetts Financial Services Co. MA purchased a new position in Option Care Health in the second quarter worth $68,003,000. Victory Capital Management Inc. grew its position in Option Care Health by 4,432.8% in the third quarter. Victory Capital Management Inc. now owns 1,621,593 shares of the company's stock worth $50,756,000 after acquiring an additional 1,585,818 shares in the last quarter. Magnetar Financial LLC grew its position in Option Care Health by 124.8% in the second quarter. Magnetar Financial LLC now owns 2,481,935 shares of the company's stock worth $68,750,000 after acquiring an additional 1,377,929 shares in the last quarter. Duquesne Family Office LLC grew its position in Option Care Health by 172.8% in the second quarter. Duquesne Family Office LLC now owns 1,871,818 shares of the company's stock worth $51,849,000 after acquiring an additional 1,185,613 shares in the last quarter. Finally, Geneva Capital Management LLC purchased a new stake in shares of Option Care Health during the third quarter worth about $24,679,000. Institutional investors own 98.05% of the company's stock.
Wall Street Analysts Forecast Growth
OPCH has been the subject of a number of analyst reports. Bank of America lowered shares of Option Care Health from a "buy" rating to a "neutral" rating and dropped their target price for the stock from $43.00 to $29.00 in a report on Wednesday, October 30th. Jefferies Financial Group lowered shares of Option Care Health from a "buy" rating to a "hold" rating and dropped their target price for the stock from $38.00 to $26.00 in a report on Thursday, October 31st. Barrington Research decreased their price target on shares of Option Care Health from $40.00 to $32.00 and set an "outperform" rating for the company in a research note on Thursday, October 31st. The Goldman Sachs Group downgraded shares of Option Care Health from a "buy" rating to a "neutral" rating and decreased their price target for the stock from $38.00 to $27.00 in a research note on Monday, November 4th. Finally, JMP Securities increased their price target on shares of Option Care Health from $36.00 to $37.00 and gave the stock a "market outperform" rating in a research note on Monday, September 30th. Three research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of $30.83.
Check Out Our Latest Report on OPCH
Option Care Health Stock Up 2.8 %
Shares of NASDAQ OPCH traded up $0.64 on Friday, reaching $23.13. 1,638,831 shares of the company's stock traded hands, compared to its average volume of 3,016,309. Option Care Health, Inc. has a 12 month low of $21.39 and a 12 month high of $34.63. The business's 50 day simple moving average is $27.62 and its two-hundred day simple moving average is $29.10. The company has a market cap of $3.94 billion, a price-to-earnings ratio of 19.44, a price-to-earnings-growth ratio of 2.33 and a beta of 1.32. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77.
Insider Buying and Selling at Option Care Health
In other news, Director Harry M. Jansen Kraemer, Jr. purchased 43,000 shares of Option Care Health stock in a transaction that occurred on Friday, November 8th. The stock was bought at an average price of $22.54 per share, with a total value of $969,220.00. Following the completion of the transaction, the director now directly owns 326,334 shares of the company's stock, valued at approximately $7,355,568.36. The trade was a 15.18 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 0.64% of the company's stock.
About Option Care Health
(
Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
See Also
Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
